[Congressional Record Volume 165, Number 166 (Monday, October 21, 2019)]
[Extensions of Remarks]
[Page E1314]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




RECOGNIZING DR. MICHAEL CALIGIURI FOR HIS GROUNDBREAKING CONTRIBUTIONS 
                        TO THE FIELD OF MEDICINE

                                 ______
                                 

                           HON. BRIAN HIGGINS

                              of new york

                    in the house of representatives

                        Monday, October 21, 2019

  Mr. HIGGINS of New York. Madam Speaker, I rise today to recognize the 
exemplary career of Dr. Michael Caligiuri who has been elected to the 
National Academy of Medicine's Class of 2018, one of the single highest 
honors in the field of medicine and healthcare.
  Dr. Caligiuri spent his formative years in Kenmore, New York, where 
he attended St. Joseph's Collegiate Institute. He then enrolled at the 
University at Buffalo to earn his undergraduate degree, and 
subsequently attended Stanford College for Medical School where he 
obtained his M.D.
  Dr. Caligiuri utilized his education to the best of his ability to 
become a leader in his profession. He served as the CEO of The James 
Cancer Hospital and Solove Research Institute, and he also directed The 
Ohio State University Comprehensive Cancer Center for fourteen years. 
In addition, he is the Immediate Past President of the American 
Association for Cancer Research, of which he was recently named a 
fellow.
  Dr. Caligiuri has served as chairperson, or in other advisory 
capacities, for countless research organizations in addition to 
conducting several of his own research protocols. His groundbreaking 
research focused on the development and activation of human natural 
killer cells and their modulation to help treat diseases like leukemia 
and brain cancer. Since these discoveries, over one thousand patients 
with cancer have been treated with clinical protocols that were 
conceived in Dr. Caligiuri's laboratory.
  In 2018, Dr. Caligiuri was named the President of the City of Hope in 
Los Angeles, a leading cancer research and treatment center. He 
conducted rigorous research and combined that with an inclusive 
leadership style to connect other healthcare institutions together in 
order to ensure the highest quality patient experience and care.
  Dr. Caligiuri's breakthrough discoveries in NK leukemia and cutaneous 
T cell lymphoma has helped get him elected to the National Academy of 
Medicine, which according to The New York Times is, ``the United 
States' most esteemed and authoritative adviser on issues of health and 
medicine, and its reports can transform medical thinking around the 
world''.
  The incredible distinction of election to the National Academy of 
Medicine has only been awarded to just over two thousand medical 
experts since 1970. Members are elected based on their professional 
achievement and commitment to service, and they do their selfless and 
consequential work without any compensation. No more than eighty 
members are elected annually. This speaks to Dr. Caligiuri's passion 
for healthcare, commitment to community service, and his overall talent 
as a medical professional. Complimenting the extraordinary 
accomplishments achieved during his career, Dr. Caligiuri is also a 
loving husband and a devoted father of three children.
  Today we recognize Dr. Michael Caligiuri for becoming an innovative 
and influential leader both in the United States and around the world 
in not only engaging in exemplary research and treatment practices, but 
also advocating for the many people whose lives have been affected by 
the devastating reality of cancer.

                          ____________________